Lopinavir pharmacokinetics in COVID-19 patients

J Antimicrob Chemother. 2020 Sep 1;75(9):2702-2704. doi: 10.1093/jac/dkaa195.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections / blood*
  • Coronavirus Infections / drug therapy
  • Cytochrome P-450 CYP3A Inhibitors / administration & dosage
  • Cytochrome P-450 CYP3A Inhibitors / blood
  • Drug Therapy, Combination
  • Female
  • Humans
  • Lopinavir / administration & dosage
  • Lopinavir / blood*
  • Male
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral / blood*
  • Pneumonia, Viral / drug therapy
  • Ritonavir / administration & dosage
  • Ritonavir / blood*
  • SARS-CoV-2

Substances

  • Cytochrome P-450 CYP3A Inhibitors
  • Lopinavir
  • Ritonavir